Methadone and Buprenorphine as Medication for Addiction Treatment Diversely Affect Inflammation and Craving Depending on Their Doses.  Leventelis C, Veskoukis AS, Rojas Gil AP, Papadopoulos P, Garderi M, Angeli A, Kampitsi A, Tsironi M. …

Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder.  Nosyk B, Min JE, Homayra F, et al.  JAMA. 2024;332(21):1822–1831. doi:10.1001/jama.2024.16954 https://jamanetwork.com/journals/jama/fullarticl…

Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder.  Nosyk B, Min JE, Homayra F, Kurz M, Guerra-Alejos BC, Yan R, Piske M, Seaman SR, Bach P, Greenland S, Karim ME, Siebert U, Bruneau J, Gustafson P, Kampman K, Korthu…

The Impact of CYP2D6 metabolizer phenotypes on the EDDP/methadone metabolic ratio: A comprehensive analysis.  Wilmes V, Kettner M, Corvest E, Verhoff MA, Kauferstein S.  Forensic Sci Int. 2025 Mar 7;370:112445. doi: 10.1016/j.forsciint.2…

Relationship Between Methadone Induction Dosing and Retention in Treatment in Opioid Treatment Programs.  Sherrick RC.  J Addict Med. 2025 Mar 10. doi: 10.1097/ADM.0000000000001473. Epub ahead of print. PMID: 40062577. Abstract https:/…

Cognitive function among methadone assisted treatment patient in Malaysia.  Surohedin IH, Ganes T, Yee A, Abd Rashid R, Lim PK.  J Ethn Subst Abuse. 2025 Feb 16:1-15. doi: 10.1080/15332640.2025.2457618. Epub ahead of print. PMID: 3995563…